| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2022 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 151.68M | 242.23M | 366.77M | 520.58M | 154.52M |
| Gross Profit | 135.50M | 154.22M | 162.28M | 165.01M | 144.25M |
| EBITDA | 622.63M | 139.15M | 132.28M | 147.06M | 103.26M |
| Net Income | 256.33M | 51.99M | 126.26M | 41.94M | 5.38M |
Balance Sheet | |||||
| Total Assets | 2.73B | 2.16B | 2.00B | 2.35B | 2.26B |
| Cash, Cash Equivalents and Short-Term Investments | 363.44M | 601.35M | 96.03M | 78.63M | 26.85M |
| Total Debt | 502.58M | 545.07M | 193.92M | 459.70M | 337.97M |
| Total Liabilities | 933.00M | 810.61M | 825.66M | 1.11B | 1.10B |
| Stockholders Equity | 1.25B | 1.02B | 869.11M | 901.95M | 864.80M |
Cash Flow | |||||
| Free Cash Flow | 55.47M | 338.40M | 96.39M | -105.39M | -18.95M |
| Operating Cash Flow | 90.82M | 340.33M | 101.63M | -104.80M | -18.41M |
| Investing Cash Flow | -520.35M | 49.90M | 55.05M | 189.41M | -106.26M |
| Financing Cash Flow | -144.60M | 123.54M | -128.09M | -46.57M | 11.62M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$3.27B | 5.50 | 8.78% | 3.59% | 10.16% | 49.48% | |
67 Neutral | HK$389.00M | 2.38 | 29.99% | ― | -5.34% | 400.80% | |
66 Neutral | HK$1.10B | 21.20 | 2.87% | 2.83% | -59.96% | -83.53% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
58 Neutral | HK$509.37M | 3.80 | 12.68% | ― | -36.59% | 48.63% | |
48 Neutral | HK$424.11M | -0.13 | -11.00% | ― | -2.11% | -779.00% | |
43 Neutral | HK$255.71M | -1.35 | -10.68% | ― | 0.97% | 33.70% |